Skip to Main Content

Chapter 14: Head and Neck Cancers

Pol Specenier; JB Vermorken

×close section menu
Expand All Sections
Jump to a Section

INTRODUCTION

Epidemiology

|Download (.pdf)|Print
Epidemiology
Incidence:

Tongue 13,590 (male: 9,720; female: 3,870. Estimated new cases for 2014 in the United States)

Mouth 11,920 (male: 7,150; female: 4,770. Estimated new cases for 2014 in the United States)

Pharynx 14,410 (male:11,550; female: 2,860. Estimated new cases for 2014 in the United States)

Larynx 12,630 (male: 10,000; female: 2,630. Estimated new cases for 2014 in the United States)
Deaths:

Tongue estimated 2,150 in 2014 (male: 1,450; female: 700)

Mouth estimated 2,070 in 2014 (male: 1,130; female: 940)

Pharynx estimated 2,540 in 2013 (male: 1,900; female: 640)

Larynx estimated 3,610 (male: 2,870 female: 740)
Median age:

Oral cavity and pharynx 62 years

Tongue 61 years

Larynx 65 years

Male to female ratio: 2.5:1

Siegel R et al. CA Cancer J Clin 2014;64:9–29

Surveillance, Epidemiology and End Results (SEER) Program, available from http://seer.cancer.gov (accessed in 2013)

Pathology

  1. Squamous carcinomas (90%)

  2. Lymphomas

  3. Salivary gland tumors (adenocarcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma)

  4. Sarcomas

  5. Melanomas

Work-up

  1. History and physical examination

  2. ENT examination

  3. Laryngoscopy with biopsy of suspicious lesions

  4. CT and/or MRI of the head and neck

  5. X-ray or CT of chest (to rule out metastatic disease or second primary tumor)

  6. Needle biopsy of lymph node not associated with obvious primary tumor

Organ Site Specific Work-up

  1. Ethmoid sinus: H&P, CT and/or MRI, CXR, pathology review if diagnosis with incomplete excision

  2. Maxillary sinus: H&P, Head and neck CT with contrast ± MRI, CXR, dental/prosthetic consultation as indicated

  3. Salivary glands: H&P, CT/MRI, CXR, pathology review

  4. Lip, oral cavity: H&P, CT/MRI, parorex, biopsy, preanesthesia studies, dental evaluation

  5. Hypopharynx: H&P, biopsy, CXR or chest CT, CT with contrast or MRI of primary and neck, examination under anesthesia with laryngoscopy/esophagoscopy, preanesthesia studies, dental evaluation, multidisciplinary consultation as indicated

  6. Glottic larynx: Same work up as for hypopharynx + CT scan with contrast and thin cuts of the larynx or MRI of primary, speech and swallowing studies

Staging

|Download (.pdf)|Print
Staging

Primary Tumor (T)

  • Differs for each site

  • For larynx and hypopharynx cancers, vocal cord paralysis indicates at least T3

  • Local invasion of adjacent structures indicates T4
|Download (.pdf)|Print
Staging

Regional Lymph Nodes (N)
NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
N2 Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
N2a Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
N2b Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MH Privacy Center Close